ReviewFrontiers in medicine2026
Diabetic dry eye: advances in pathogenesis, diagnostic strategies, and therapeutic approaches.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dry eye is the most common ocular surface disorder that is increasingly acknowledged to be associated with diabetes mellitus. Via metabolic dysregulation and neural injury, diabetes mellitus significantly increases the prevalence of dry eye, adversely affecting patients' quality of life. At present, the diagnosis and treatment of diabetic dry eye are still facing challenges in clinical practice. This article outlines the prevalence and risk factors associated with diabetic dry eye, explores its underlying pathogenic mechanisms, such as advanced glycation end-product accumulation, oxidative stress, corneal neuropathy, and impaired neural regulation, which collectively disrupt the lacrimal functional unit, leading to reduced tear secretion and tear film instability. The clinical manifestations of diabetic dry eye are also reviewed. According to current literature, diagnostic strategies utilizing confocal microscopy and tear fluid biomarkers are proposed. In addition, this review summarizes recent therapeutic advances and potential intervention strategies for diabetic dry eye, with a focus on emerging mechanism-based treatments. Taken together, this review aims to advance research on diabetic dry eye and offer novel insights to support early diagnosis and precision therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.